Purpose Proper adherence and persistence to medications are crucial for better quality of
life and improved outcomes in rheumatoid arthritis (RA), psoriasis (PsO), and psoriatic …

Objectives To identify factors associated with adherence to medication for rheumatoid
arthritis or undifferentiated inflammatory arthritis using a systematic literature search …

Background Studies indicate adherence to biologics among patients with psoriasis is low,
yet little is known about their use in the Medicare population. Objective We sought to …

Objective We examined whether nonadherence to hydroxychloroquine (HCQ) or
immunosuppressive medications (ISMs) was associated with higher subsequent acute care …

Abstract Objective. Non-adherence to DMARDs is common, but little is known about
adherence to biologic therapies and its relationship to treatment response. The purpose of …

Introduction Despite the availability of multiple effective therapies, discontinuation/switching
of treatment is common for many patients with rheumatoid arthritis (RA). This study was …

Background Real-world data on treatment patterns associated with use of interleukin-17A
inhibitors in psoriasis are lacking. Objective To compare treatment patterns between …

Objective We aimed to estimate the prevalence and predictors of optimal adherence and
persistence to the disease-modifying therapies (DMT) for multiple sclerosis (MS) in 3 …

Chronic inflammatory diseases (CIDs) represent a substantial clinical and economic burden
to patients, providers, payers and society overall. Biologics, such as tumor necrosis factor …

Objective. Reported adherence in rheumatoid arthritis (RA) varies widely (10.5–98.5%).
Variability may result in part from different methods used to measure adherence. Our aims …